10-Q: Trustfeed Corp. Reports Q2 2024 Results, Announces Polomar Merger and License Agreement
Quarterly Report
Trustfeed Corp. reports no revenue for Q2 2024, finalizes merger agreement with Polomar Specialty Pharmacy, and enters into a license agreement with Pinata Holdings.
Summary
- Trustfeed Corp. released its financial results for the second quarter of 2024.
- The company reported no revenue for the three and six months ended June 30, 2024.
- Operating expenses decreased to $20,116 for the three months ended June 30, 2024, from $90,958 for the three months ended June 30, 2023.
- Operating expenses decreased to $89,140 for the six months ended June 30, 2024, from $180,794 for the same period ended June 30, 2023.
- The company recorded a net loss of $20,116 and $89,140 for the three and six months ended June 30, 2024, respectively.
- As of June 30, 2024, Trustfeed had total current assets of $294 and total current liabilities of $102,973, resulting in a working capital deficit of $(102,679).
- The company's auditors have raised substantial doubt about its ability to continue as a going concern.
- Trustfeed entered into a merger agreement with Polomar Specialty Pharmacy on June 28, 2024.
- Trustfeed executed a license agreement with Pinata Holdings on June 29, 2024, to license intellectual property rights related to drug delivery.
Sentiment
Score: 3
Explanation: The sentiment is low due to the lack of revenue, going concern warning, and material weaknesses in internal controls. The potential merger and license agreement offer some hope, but the company faces significant challenges.
Positives
- Operating expenses decreased significantly compared to the same periods in the previous year.
- The company is pursuing a merger with Polomar Specialty Pharmacy, which could provide new business opportunities.
- Trustfeed has secured a license agreement with Pinata Holdings for intellectual property rights related to drug delivery.
Negatives
- The company reported no revenue for the three and six months ended June 30, 2024.
- Trustfeed has a significant working capital deficit.
- The company's auditors have raised substantial doubt about its ability to continue as a going concern.
- The company has an accumulated deficit of $1,487,473 as of June 30, 2024.
Risks
- The company's ability to continue as a going concern is dependent on its ability to generate revenues and raise capital.
- There is no guarantee that the company will raise sufficient capital to continue operations.
- The company's disclosure controls and procedures were not effective due to material weaknesses in internal control over financial reporting.
- The company faces risks related to failure to obtain adequate financing on a timely basis and on acceptable terms.
- The company faces uncertainty with respect to intellectual property rights, protecting those rights and claims of infringement of others intellectual property.
Future Outlook
The company anticipates entering into a future transaction involving the acquisition of one or more businesses, companies, or asset classes. The company is also evaluating its Pre-Existing Business and expects to permanently shut down, spin off, or assign it at the time of such future transaction(s).
Management Comments
- Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the consolidated financial statements are issued and determined that substantial doubt exists about the Company's ability to continue as a going concern.
- Over the next twelve months management plans to raise additional capital and to invest its working capital resources in other potential business opportunities including a business combination with Polomar pursuant to the Merger Agreement or possibly another third-party.
Industry Context
The company's shift from cannabis and renewable energy to a technology company and now potentially to a specialty pharmacy business reflects a broader trend of companies seeking growth opportunities in emerging sectors. The merger with Polomar and the license agreement with Pinata suggest a strategic move into the pharmaceutical space, which is a highly regulated but potentially lucrative market.
Comparison to Industry Standards
- Given the lack of revenue and the going concern warning, Trustfeed's financial performance is significantly below industry standards for publicly traded companies.
- Comparable companies in the specialty pharmacy sector, such as CVS Health (CVS) and Walgreens Boots Alliance (WBA), generate billions in revenue and have strong balance sheets.
- Smaller, emerging specialty pharmacy companies often rely on venture capital or private equity funding to support their growth, which Trustfeed appears to be attempting through related party loans and potential future capital raises.
- The merger with Polomar is likely an attempt to quickly gain access to revenue and market share in the specialty pharmacy space, but the success of this strategy will depend on Polomar's existing operations and the integration process.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President, Chief Financial Officer, Secretary and Treasurer | Brett Rosen | Terrence M. Tierney | 2024-03-21 | Brett Rosen resigned from all of his officer and director positions with the Company. |
| Director | Vacancy | Gabriel Del Virginia | 2024-07-18 | To fill a vacancy on the Board. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Articles of Incorporation | To effect a change of name from Trustfeed Corp. to Polomar Health Services, Inc. | Subsequent Event | Reflects the company's intention to align its name with its new business focus. |
| Amendment to Articles of Incorporation | To effect an increase in the number of authorized shares of the Company's blank check preferred stock to 5,000,000. | Subsequent Event | Provides the company with greater flexibility in issuing preferred stock for financing or other corporate purposes. |
| Amendment to Articles of Incorporation | To authorize, but not require, an amendment to the Existing Articles, to effect a reverse stock split (the Reverse Stock Split) with a ratio of 1-for-10. | Subsequent Event | Could increase the company's stock price and potentially attract new investors, but also reduces the number of outstanding shares. |
| Adoption of 2024 Equity and Incentive Compensation Plan | Adoption of the Company's 2024 Equity and Incentive Compensation Plan. | Subsequent Event | Provides the company with a tool to attract, retain, and incentivize employees and directors. |
Related Party Transactions
- During the six months ended June 30, 2024, the Company borrowed $80,171 from a shareholder for payment of operating expenses.
- The advances have 0% interest and are due upon demand.
- Pinata is an affiliate of CWR 1, LLC, the Company's majority shareholder, through common ownership.
- An affiliate of CWR 1, LLC owns a majority of the membership interests of Polomar.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial condition and going concern warning.
- Employees may experience uncertainty due to the company's restructuring and potential business combination.
- Customers of the Pre-Existing Business may be affected by the suspension of operations.
- The merger with Polomar could create new opportunities for stakeholders if the combined company is successful.
Next Steps
- The company intends to implement the proposed corporate actions approved on July 11, 2024, including a name change, increase in authorized shares of preferred stock, and a potential reverse stock split.
- The company plans to complete the merger with Polomar Specialty Pharmacy.
- The company intends to utilize the IP Rights licensed from Pinata Holdings in products expected to be manufactured and distributed subsequent to its planned acquisition of Polomar.
Key Dates
| Date | Description |
|---|---|
| 2000-09-14 | Trustfeed Corp. was incorporated in the State of Nevada under the name of Telemax Communications. |
| 2003-07-24 | The name was changed to HealthMed Services, Ltd. |
| 2021-04-16 | Fastbase, Inc. and SCI Inc. entered into a Share Purchase Agreement with Mr. James Shipley. |
| 2021-04-21 | The Share Purchase transaction closed, and Mr. Shipley resigned from his positions. |
| 2021-09-14 | Trustfeed entered into a Contribution Agreement with Fastbase for the acquisition of certain assets. |
| 2022-09-02 | Trustfeed conducted a reverse split and changed its name to Trustfeed Corp. |
| 2022-10-26 | Fastbase requested that the board of directors cancel and return to unissued capital stock, the remaining shares of its Series A Convertible Preferred Stock. |
| 2022-11-04 | Trustfeed cancelled all outstanding shares of Series A Preferred Stock, save 500,000 shares of Series A Convertible Preferred Stock which were outstanding and then held by Fastbase. |
| 2023-06-03 | The Board authorized the execution of a reverse split of the issued and outstanding shares of the Company's common stock at a ratio of up to one post-split share per two thousand pre-split shares (1:2,000). |
| 2023-12-29 | Fastbase sold the Transferred Shares to CWR 1, LLC, and Rasmus Refer resigned from his positions. |
| 2024-03-21 | Brett Rosen resigned from all of his officer and director positions with the Company, and he was replaced in all such positions by Terrence M. Tierney. |
| 2024-06-28 | Trustfeed entered into a Merger Agreement with Polomar Acquisition, L.L.C. and Polomar Specialty Pharmacy, LLC. |
| 2024-06-29 | Trustfeed executed a Know How and Patent License Agreement with Pinata Holdings, Inc. |
| 2024-06-30 | End of the quarterly period. |
| 2024-07-11 | A holder representing 84.3% of the voting capital stock of the Company and the Board by written consent in lieu of a meeting, approved the following corporate actions. |
| 2024-07-18 | Gabriel Del Virginia was appointed as a director to fill a vacancy on the Board. |
| 2024-08-01 | The definitive Information Statement on Schedule 14C was filed with the SEC. |
| 2024-08-08 | The definitive Information Statement on Schedule 14C was mailed to all know beneficial shareholders and shareholders of record. |
| 2024-08-09 | 109,138,049 common shares outstanding. |
| 2024-08-14 | Date of report filing. |
Keywords
Merger, Polomar, License Agreement, Financial Results, Trustfeed Corp, Going Concern, Operating Expenses, Net Loss, Revenue
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.